罕见病研究2024,Vol.3Issue(1) :36-41.DOI:10.12376/j.issn.2097-0501.2024.01.005

中国结节性硬化症相关肾血管平滑肌脂肪瘤诊疗的发展和现状

The Development and Current Status in the Diagnosis and Management of Tuberous Sclerosis Complex Associated with Renal Angiomyolipoma in China

王文达 张玉石
罕见病研究2024,Vol.3Issue(1) :36-41.DOI:10.12376/j.issn.2097-0501.2024.01.005

中国结节性硬化症相关肾血管平滑肌脂肪瘤诊疗的发展和现状

The Development and Current Status in the Diagnosis and Management of Tuberous Sclerosis Complex Associated with Renal Angiomyolipoma in China

王文达 1张玉石1
扫码查看

作者信息

  • 1. 中国医学科学院北京协和医院泌尿外科,北京 100730
  • 折叠

摘要

结节性硬化症(TSC)是一种由TSC1 和TSC2 基因突变引起的罕见常染色体显性遗传病,可引发多器官病变,肾脏病变主要是肾血管平滑肌脂肪瘤(RAML).近年来,随着国内对TSC-RAML的认识不断加深,在诊疗上逐渐规范并完善,同时进行发病机制和治疗方面的探索.本文对中国TSC-RAML的诊疗研究发展进行回顾并展望.

Abstract

Tuberous sclerosis complex(TSC)is a rare autosomal dominant genetic disorder caused by mutations in the TSC1 or TSC2 genes.The disease can cause multiple organ lesions.The most common renal le-sions are renal angiomyolipoma(RAML).In recent years,China has made progresss in the understanding of TSC-RAML,so that the standardization of the diagnosis and management of TSC-RAML have improved.Efforts have been taken in the studies of the pathogenesis and treatment of TSC-RAML.This article reviews the diagno-sis,therapy,and research development of TSC-RAML in China.

关键词

结节性硬化症/肾血管平滑肌脂肪瘤/诊疗进展

Key words

tuberous sclerosis complex/renal angiomyolipoma/progress of diagnosis and treatment

引用本文复制引用

基金项目

中央高水平医院临床科研业务费(2022-PUMCH-A-151)

出版年

2024
罕见病研究

罕见病研究

CSTPCD
ISSN:
参考文献量9
段落导航相关论文